Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

Share Price is delayed by 15 minutes
Get Live Data
1,717.00    -37.00 (-2.11%)
Bid:
1,715.00
Ask:
1,717.00
Spread: 2.00 (0.117%)
Market Cap: £5.50b
HSX Live PriceLast checked at - London Stock Exchange

Intraday Hiscox Share Chart

Kiskadee update

19 Jan 2015 08:22

RNS Number : 4890C
Hiscox Ltd
19 January 2015
 



 

 

Hiscox announces strong inflows to the Kiskadee ILS Funds

 

 

Hamilton, Bermuda, (19 January, 2015) - Hiscox today announces that total assets under management in its Kiskadee insurance-linked strategies (ILS) funds, have grown to over $400 million at 1 January 2015. Commitments from existing investors have been complemented by strong inflows from new investors, and Kiskadee has also received firm commitments of additional capital for deployment between now and the summer 2015 reinsurance renewal season.

 

The Kiskadee Diversified Fund Ltd and Kiskadee Select Fund Ltd are actively managed open-ended Bermuda domiciled funds. The Kiskadee funds offer investors greater capital efficiency and market access than traditional direct collaterelised ILS funds through their alignment with Hiscox. This structure enables the construction of investible portfolios from a broad and more diverse universe of reinsurance and retrocession risks.

 

Jeremy Pinchin, CEO, Hiscox Re, commented "Our Kiskadee funds combine superior risk selection with diversified market access provided by the Hiscox Group. We believe this is a truly distinctive offering and so are pleased at the enthusiastic response from new and existing investors. Hiscox has a long history of managing alternative forms of capital. Kiskadee is a natural continuation of working with like-minded, long-term partners and offering enhanced solutions to our reinsurance clients."

 

Ends

 

For further information please contact:

Hiscox Ltd

Kylie O'Connor +44 (0) 20 7448 6656 Kylie.O'Connor@HISCOX.com

 

Brunswick

Tom Burns +44 (0) 20 7404 5959 TBurns@brunswickgroup.com 

 

Notes to editors

 

About Kiskadee

Kiskadee Investment Managers, a wholly owned subsidiary of specialist insurer Hiscox, provides investors with the access to the substantial insurance and reinsurance resources of the Hiscox Group. In addition to our flagship Kiskadee Diversified and Kiskadee Select Funds the investment management platform offers single investor funds and bespoke vehicles for tailored insurance, reinsurance portfolios and larger investment allocations.

 

 

About Hiscox

 

Hiscox, the international specialist insurer, is headquartered in Bermuda and listed on the London Stock Exchange (LSE:HSX). There are three main underwriting divisions in the Group - Hiscox London Market, Hiscox Re and Hiscox Retail (which includes Hiscox UK and Europe, Hiscox Guernsey, Hiscox USA and subsidiary brand, DirectAsia). Hiscox underwrites internationally traded, bigger ticket business and reinsurance through Hiscox Re and Hiscox London Market. Through its retail businesses in the UK, Europe and the US Hiscox offers a range of specialist insurance for professionals and business customers, as well as homeowners. For further information, visit www.hiscoxgroup.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCVKLBFEFFLBBF
Date   Source Headline
2nd Dec 20191:15 pmRNSTotal Voting Rights
13th Nov 20197:00 amRNSDirector/PDMR Shareholding
11th Nov 20195:12 pmRNSTR-1: Standard form-notification of major holdings
7th Nov 20192:08 pmRNSHiscox Ltd market announcement
4th Nov 20197:01 amRNSHiscox Ltd Q3 Trading Statement
4th Nov 20197:00 amRNSSyndicates 33 and 6104 - estimates
1st Nov 20193:27 pmRNSTotal Voting Rights
1st Oct 20194:39 pmRNSDirector/PDMR Shareholding
1st Oct 20194:30 pmRNSTotal Voting Rights
20th Sep 20192:35 pmRNSDirector/PDMR Shareholding
18th Sep 20194:18 pmRNS2020 Syndicate Business Forecast
17th Sep 20195:35 pmRNSDirector/PDMR Shareholding
13th Sep 20195:16 pmRNSDirector/PDMR Shareholding
9th Sep 20191:15 pmRNSApplication to be Admitted to Official List
5th Sep 20197:00 amRNSAppointment of Group Chief Underwriting Officer
3rd Sep 20192:40 pmRNSTotal Voting Rights
27th Aug 20194:06 pmRNSAnnouncement of Scrip Reference Share Price
20th Aug 20193:35 pmRNSDirector/PDMR Shareholding
19th Aug 20195:28 pmRNSTR-1: Standard form-notification of major holdings
7th Aug 20191:21 pmRNSDirector/PDMR Shareholding
2nd Aug 201911:40 amRNSTotal Voting Rights
1st Aug 20192:33 pmRNSApplication for Block Listing
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
29th Jul 20197:01 amRNSHiscox Ltd interim results
29th Jul 20197:00 amRNSSyndicates 33 and 6104 - estimates
17th Jul 20191:37 pmRNSTR-1: Standard form-notification of major holdings
12th Jul 20197:00 amRNSTrading update
1st Jul 20194:53 pmRNSTotal Voting Rights
27th Jun 20197:00 amRNSRichard Watson - Retirement
18th Jun 20194:22 pmRNSDirector/PDMR Shareholding
18th Jun 20194:22 pmRNSDirector/PDMR Shareholding
10th Jun 20192:45 pmRNSApplication to be Admitted to Official List
3rd Jun 20191:51 pmRNSTotal Voting Rights
30th May 20193:29 pmRNSAnnouncement of Scrip Reference Share Price
23rd May 20194:55 pmRNSDirector/PDMR Shareholding
16th May 20196:28 pmRNSEGM Results
16th May 20196:28 pmRNSResult of AGM
15th May 20193:06 pmRNSBLOCK LISTING SIX MONTHLY RETURN
10th May 201912:21 pmRNSDirector/PDMR Shareholding
7th May 20197:01 amRNSHiscox Ltd Q1 Trading Statement
7th May 20197:00 amRNSSyndicates 33 and 6104 - estimates
1st May 20193:43 pmRNSTotal Voting Rights
30th Apr 20193:13 pmRNSNotice of 2019 Extraordinary General Meeting
11th Apr 20197:00 amRNSDirector/PDMR Shareholding
11th Apr 20197:00 amRNSDirector/PDMR Shareholding
11th Apr 20197:00 amRNSDirector/PDMR Shareholding
5th Apr 20193:18 pmRNSDirector/PDMR Shareholding
1st Apr 20192:44 pmRNSTotal Voting Rights
1st Apr 20192:44 pmRNSDirector/PDMR Shareholding
19th Mar 20195:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.